Interleukin-16 is also known as lymphocyte chemoattractant factor (LCF) and acts as chemoattractant for human T cells. IL-16 is secreted by cells of immune system such as T cells, dendritic cells and eosinophils. It is also secreted by the non-immune cells such as endothelial cells, fibroblasts and neurons. IL-16 is biologically active in the multimeric form and binds to CD4 and CCR5 receptors. The signaling induced by IL-16 activates pathways that involve MAPK, PI3K and SAPK. The biological activities of IL-16 are important for inflammation, migration, cell cycle progression, cell proliferation, development of Th1 cells and regulation of T cell responses. IL-16 signaling is important in the pathophysiology of Crohn′s disease, HIV infection, airway inflammation in asthma and rheumatoid arthritis. Anti-Interleukin-16 antibody recognizes human IL-16.
Immunogen
recombinant human IL-16 expressed in E. coli.
Application
Anti-Interleukin-16 antibody may be used for immunoblotting at a working antibody concentration of 0.1-0.2 μg/ml. For ELISA, a working concentration of 0.5-1.0 μg/ml is recommended.
Physical form
Lyophilized from a 0.2 μm filtered solution in phosphate buffered saline.
Journal of leukocyte biology, 67(6), 757-766 (2000-06-17)
Interleukin 16 (IL-16) was initially described in 1982 as the first T cell chemoattractant. Through interaction with CD4, IL-16 has now been characterized as a chemoattractant for a variety of CD4+ immune cells. Recent in vivo studies have more fully
Monocytes or T cells in Crohn's disease: does IL-16 allow both to play at that game?
S Schreiber
Gut, 49(6), 747-748 (2001-11-16)
Questions
Reviews
★★★★★ No rating value
Active Filters
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.